Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab + S-1 + Albumin Paclitaxel in Advanced Biliary Tract Cancer
NCT04027764Phase 2Unknown
- Start
- May 2019
- Primary completion
- May 2020
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in biliary tract cancer (BTC). Status: unknown.
02
Drugs
toripalimab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04027764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027764.